findmyKOL

Andrea Synowiec, DO

Basic profile

Allegheny Health Network

ORCIDNPI
RegionPittsburgh, PA · NortheastSpecialtyNeurologyFocusNeurology
ActivityNot yet indexedEmergingfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Andrea Synowiec is a Neurology physician affiliated with Allegheny Health Network. OpenAlex indexes 18 publications with 217 citations (h-index 5).

Overview

Scholarship

indexed output and impact (OpenAlex)
18publications

Distinct works indexed by OpenAlex, matched via ORCID.

217citations

Total citations across indexed works.

5h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
32companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Industry payments

32 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

32 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Musculoskeletal

    67.7%
    Neuromuscular Blocker66.1%
    Onabotulinumtoxina98%Botox2%
    Part D + Part B34 patients
    Nonsteroidal Anti-inflammatory Drug1%
    Diclofenac Potassium43%Diclofenac Sodium36%Naproxen21%
    Part D<11 patients

    + 2 more classes in this area

  • Nervous system

    29.6%
    Other antiepileptics6.6%
    Topiramate51%Levetiracetam30%Lacosamide10%Trokendi Xr9%
    Part D<11 patients
    Calcitonin gene-related peptide (CGRP) antagonists3.9%
    Emgality Pen44%Aimovig Autoinjector18%Ajovy Autoinjector18%Ajovy Syringe13%Emgality Syringe7%
    Part D<11 patients

    + 13 more classes in this area

  • Cardiovascular

    1.8%
    Beta blocker1.4%
    Propranolol Hcl Er83%Propranolol Hcl17%
    Part D<11 patients
    Calcium channel blocker0.4%
    Verapamil Er100%
    Part D<11 patients
Where care is delivered (Part B)3.5% facility · 96.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”